All-at-Once Spatial Proteome Profiling with PSPro: Technical Advances and Implications

Study Background and Research Question

Dissecting the molecular architecture of complex tissues is a central challenge in systems biology, oncology, and immunology. In multicellular environments, individual cell types exhibit unique proteomic profiles and orchestrate their functions through spatially organized interactions. Classical spatial proteomics methods—such as laser microdissection-mass spectrometry (LMD-MS) and antibody-based imaging—have enabled region- or marker-specific mapping, but they often force trade-offs between spatial precision, throughput, and depth of proteome coverage. These limitations hinder our understanding of cellular heterogeneity and microenvironmental influences in health and disease. Mao et al. addressed the question: Can spatial proteome profiling be achieved at single-cell-type resolution, with high throughput and proteomic depth, from a single tissue slice?

Key Innovation from the Reference Study

The core innovation of Mao et al.'s study is the development of PSPro (Proximity labeling for Spatial Proteomics)—a method that leverages antibody-directed enzymatic biotinylation to selectively tag and enrich the proteome of specific cell types in situ. By combining optimized proximity labeling with efficient affinity purification, PSPro transforms the traditional "antibody-epitope" paradigm into an "antibody-cell-type proteome" workflow. This approach achieves all-at-once, multiplexed proteome capture with sub-micrometer precision, enabling cell-type-specific spatial profiling within a single tissue slice. The innovation lies in both the fine-tuning of labeling parameters for selectivity and coverage, and in the streamlined workflow that allows for robust benchmarking against established flow cytometry and LMD-based techniques.

Methods and Experimental Design Insights

PSPro integrates antibody-based targeting, proximity-dependent biotinylation, and downstream affinity purification to isolate cell-type-specific proteomes from complex tissues. The workflow proceeds as follows:

• Antibody Targeting: Primary antibodies recognizing cell-type-specific markers are applied to fixed tissue sections.
• Proximity Labeling: A secondary antibody conjugated to a biotinylating enzyme (typically horseradish peroxidase, HRP) is introduced. Upon addition of a tyramide substrate, HRP catalyzes covalent deposition of biotin or fluorophore near the antibody–antigen complex—this is a classic horseradish peroxidase catalyzed tyramide deposition mechanism, widely used for signal amplification for immunohistochemistry and fluorescent labeling for in situ hybridization.
• Affinity Enrichment: Biotin-tagged proteins are captured via streptavidin beads, enabling proteomic analysis by mass spectrometry.
• Spatial Integration: The protocol is compatible with laser microdissection, allowing spatially resolved proteomics of subpopulations within the same tissue slice.

Mao et al. optimized labeling conditions—such as antibody concentration, substrate incubation time, and washing steps—to maximize selectivity while retaining proteome coverage. Benchmarking experiments compared PSPro to flow cytometry- and LMD-based workflows, validating its specificity and reproducibility.

Protocol Parameters

• Antibody incubation: Empirically determined for each tissue type; extended incubation (overnight at 4°C) improves marker specificity.
• HRP-tyramide reaction time: Short (typically 5–10 minutes) to prevent off-target labeling and maintain high spatial precision, as supported by established product protocols and the reference workflow.
• Washing steps: Multiple, high-stringency washes post-labeling to reduce background and remove unbound reagents.
• Affinity capture: Use of streptavidin magnetic beads for robust and rapid enrichment of biotinylated proteins.
• Mass spectrometry: Peptide-level analysis of enriched proteome fractions for cell-type identification and quantification.

Researchers are encouraged to fine-tune these parameters based on tissue type, antibody performance, and the abundance of target proteins.

Core Findings and Why They Matter

PSPro enabled Mao et al. to systematically profile the proteomes of ten distinct cell types within pancreatic tumor and spleen tissue slices. The method enriched thousands of proteins, including numerous low-abundance markers, and demonstrated high selectivity and coverage when benchmarked against established approaches. Notably, by integrating laser microdissection, PSPro revealed spatial heterogeneity among cancer cell and immune cell subpopulations within the same tumor slice, offering insights into the microenvironmental architecture that are inaccessible by bulk or region-based profiling. These findings have direct implications for studies of tumor heterogeneity, immune infiltration, and tissue remodeling, as spatially resolved proteomics at single-cell-type resolution is essential for elucidating functional crosstalk in complex disease states.

Comparison with Existing Internal Articles

Several internal resources discuss the practical implementation of signal amplification for immunohistochemistry and related workflows. For example, the scenario-driven guide Scenario-Driven Guidance: Cy5 TSA Fluorescence System Kit offers actionable strategies for reproducible, high-sensitivity detection of low-abundance targets, aligning with the requirements of spatial proteomics workflows such as PSPro. Similarly, the article Advanced Signal Amplification highlights rapid, HRP-catalyzed fluorescence enhancement for robust detection in complex tissues. These resources emphasize the mechanistic underpinnings of immunocytochemistry fluorescence enhancement and tyramide signal amplification, which are integral to the labeling steps of PSPro. However, Mao et al.'s method advances beyond single-marker detection to large-scale, multiplexed proteome capture, representing a substantial leap in technical capability and research utility.

Limitations and Transferability

Despite its strengths, PSPro has several limitations. First, the reliance on high-quality, cell-type-specific antibodies may restrict its applicability in tissues where such markers are poorly characterized. Second, the efficiency of biotinylation and subsequent affinity capture can vary with tissue fixation and processing, necessitating empirical optimization for new sample types. Third, while PSPro achieves impressive spatial and proteomic resolution, the throughput may be constrained by the number of parallel antibody incubations and enrichment steps. Finally, as with all antibody-guided technologies, non-specific labeling and cross-reactivity remain technical concerns, requiring rigorous controls and validation.

Nevertheless, the principles underlying PSPro—namely, enzymatic proximity labeling and affinity enrichment—are broadly transferable to a range of spatial biology applications. With adaptation, the workflow could be applied to study diverse tissues, developmental systems, or pathological contexts where cell-type-resolved proteomic information is sought.

Research Support Resources

Researchers aiming to implement or adapt proximity labeling workflows for spatial proteomics or fluorescent signal amplification kit approaches can leverage commercially available systems. The Cy5 Tyramide Signal Amplification (TSA) Fluorescence System Kit (SKU: K1052, APExBIO) is designed for sensitive and specific HRP-catalyzed tyramide deposition, enabling robust detection of low-abundance targets in immunohistochemistry, immunocytochemistry, and in situ hybridization. This kit supports precise, rapid labeling compatible with both standard and confocal microscopy, and can be integrated into workflows modeled on PSPro for enhanced spatial proteomic analysis.